Unique ID issued by UMIN | UMIN000036571 |
---|---|
Receipt number | R000041448 |
Scientific Title | The efficacy of fractional flow reserve-guided percutaneous coronary intervention for patients with angina pectoris: A network meta-analysis |
Date of disclosure of the study information | 2019/04/24 |
Last modified on | 2019/04/24 11:33:14 |
The efficacy of fractional flow reserve-guided percutaneous coronary intervention for patients with angina pectoris: A network meta-analysis
The efficacy of fractional flow reserve-guided percutaneous coronary intervention for patients with angina pectoris: A network meta-analysis
The efficacy of fractional flow reserve-guided percutaneous coronary intervention for patients with angina pectoris: A network meta-analysis
The efficacy of fractional flow reserve-guided percutaneous coronary intervention for patients with angina pectoris: A network meta-analysis
Japan |
Angina pectoris
Cardiology | Cardiovascular surgery |
Others
NO
To confirm whether FFR-guided PCI improves prognosis compared to other treatments
Efficacy
Others
Others
Not applicable
All-cause mortality
Myocardial infarction
Others,meta-analysis etc
Not applicable |
Not applicable |
Male and Female
The studies fulfilling the following criteria were included in the analyzes : randomized controlled trials ; studies including patients with AP as study participants; studies involving at least two treatments among FFR-guided PCI, CABG, non-FFR-guided PCI, and MT; and studies with all-cause mortality as an outcome, and studies had at least 1-year follow up period. FFR-guided PCI was defined as PCI for coronary artery stenosis with an FFR of 0.80 or less in the target vessel and non-FFR-guided PCI group was defined as PCI without FFR evaluation.
Exclusion criteria were as follows: literature reviews or case reports, studies including participants requiring emergency intervention, studies including participants with myocardial infarction within 72 hours prior to enrollment
5000
1st name | Hiroki |
Middle name | |
Last name | Shinohara |
The University of Tokyo Hospital
Department of Cardiovascular Medicine
113-8655
7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan
03-3815-5411
hshinohara-gun@umin.ac.jp
1st name | Hiroki |
Middle name | |
Last name | Shinohara |
The University of Tokyo Hospital
Department of Cardiovascular Medicine
113-8655
7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan
03-3815-5411
hshinohara-gun@umin.ac.jp
Tokyo University
Japan Society for the Promotion of Science
Other
None
None
-
-@-
NO
2019 | Year | 04 | Month | 24 | Day |
Unpublished
16187
The study included 16187 patients from 15 RCTs. Network meta analysis (NMA) showed that the all-cause mortality of FFR-guided PCI was not significantly different than those of the other treatment groups (CABG, OR 1.1, 95% CI 0.66, 1.7; non FFR guided PCI, OR 0.85, 95% CI 0.53, 1.4; and MT, OR 0.82, 95% CI 0.52, 1.3). The NMA for MI, including 13548 patients from 12 RCTs, showed that FFR guided PCI tended to reduce the occurrence of MI compared with MT (OR 0.60, 95% CI 0.36, 1.0).
2019 | Year | 04 | Month | 03 | Day |
All-cause mortality, Myocardial infarction.
Completed
2019 | Year | 03 | Month | 08 | Day |
2019 | Year | 03 | Month | 08 | Day |
2019 | Year | 03 | Month | 08 | Day |
2019 | Year | 03 | Month | 08 | Day |
Multiple databases were searched for studies from 2000 to 2018, and a NMA was performed to compare outcomes with FFR guided PCI, non FFR guided PCI, CABG, and MT for AP based on estimated odds ratios. Treatments were ranked by the surface under the cumulative ranking curve.
2019 | Year | 04 | Month | 22 | Day |
2019 | Year | 04 | Month | 24 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041448
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |